Semaglutide is generally perfectly tolerated with identical dropout rates when compared with placebo, although it may be fewer nicely tolerated than dulaglutide (Trulicity).1,three The most common adverse outcomes are nausea, vomiting, and diarrhea and can be experienced by about thirty% of peop